Mark R. Ziebell - Jun 28, 2023 Form 4 Insider Report for Avid Bioservices, Inc. (CDMO)

Signature
/s/ Mark R. Ziebell
Stock symbol
CDMO
Transactions as of
Jun 28, 2023
Transactions value $
-$47,459
Form type
4
Date filed
6/30/2023, 08:13 PM
Previous filing
May 2, 2023
Next filing
Jul 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDMO Common Stock, $0.001 par value Options Exercise +10.5K +26.2% 50.6K Jun 28, 2023 Direct F1
transaction CDMO Common Stock, $0.001 par value Sale -$30.2K -2.38K -4.69% $12.70 48.3K Jun 29, 2023 Direct F2, F3
transaction CDMO Common Stock, $0.001 par value Sale -$17.3K -1.28K -2.65% $13.49 47K Jun 30, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDMO Performance Stock Units (FY 2022 Grant) Options Exercise $0 -3.79K -6.86% $0.00 51.4K Jun 28, 2023 Common Stock 3.79K Direct F1, F4, F5
transaction CDMO Performance Stock Units (FY 2022 Grant) Disposed to Issuer $0 -3.64K -7.08% $0.00 47.8K Jun 28, 2023 Common Stock 3.64K Direct F1, F4, F6
transaction CDMO Performance Stock Units (FY 2023 Grant) Options Exercise $0 -6.72K -14.07% $0.00 41.1K Jun 28, 2023 Common Stock 6.72K Direct F1, F4, F5
transaction CDMO Performance Stock Units (FY 2023 Grant) Disposed to Issuer $0 -6.73K -16.38% $0.00 34.3K Jun 28, 2023 Common Stock 6.73K Direct F1, F4, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each performance stock unit ("PSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
F2 Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the PSUs described in footnote 4. This sale does not represent a discretionary trade by the reporting person.
F3 Represents a weighted average sales price per share. These shares were sold at prices ranging from $12.70 to $12.80. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 The PSUs granted to the reporting person vest based on the Issuer achieving certain fiscal year financial milestones over three (3) consecutive fiscal year performance periods (i.e., May 1 to April 30) commencing with the fiscal year in which the PSU was initially granted (each fiscal year a "Performance Period"). Subject to the Issuer attaining the applicable fiscal year milestones, 1/3rd of the PSUs will vest on the last day of each fiscal year during the Performance Period, subject to the reporting person's continuous service to the Issuer on such vesting dates. The number of PSUs initially reported by the reporting person was based on a maximum 200% achievement of each milestone during each Performance Period (the "Maximum Performance Target"). If a milestone is achieved at a rate below the Maximum Performance Target, or is not achieved, the corresponding portion of the PSUs that do not vest are forfeited.
F5 Vested PSUs settled into shares of the Issuer's Common Stock on the fifth business day following the chief financial officer's certification of the Issuer's achievement of the milestones for the Performance Period ended April 30, 2023.
F6 Represents the forfeiture of unearned PSUs for the Performance Period ended April 30, 2023.